Key result
Elevated EASIX linked to ~46% higher all-cause mortality in hypertension.
Why the study?
Emerging evidence links the Endothelial Activation and Stress Index (EASIX) to mortality in coronary artery disease, but its relevance in hypertensive patients remains unclear.
Does a higher EASIX score predict increased all-cause and cardiovascular mortality in hypertensive individuals?
Cohort (n=6,138)
Yes
Does a higher EASIX score predict increased all-cause and cardiovascular mortality in hypertensive individuals?
Hazard Ratio: 1.46 (95% CI 1.23–1.73)
p-value: p=<0.0001
The Endothelial Activation and Stress Index (EASIX), calculated from routine labs, is a significant and independent predictor of long-term all-cause and cardiovascular mortality in patients with hypertension.
Emerging evidence links the Endothelial Activation and Stress Index (EASIX) and mortality risk in coronary artery disease, but its relevance in hypertensive patients remains unclear. This study examines the association between EASIX and all-cause and cardiovascular mortality in hypertensive individuals. The analysis included 6138 hypertensive patients from seven National Health and Nutrition Examination Survey (NHNES) cycles (2003-2016), with mortality data obtained from the National Death Index (NDI). Over a median follow-up of 98 months, 1435 (23.4%) participants died, including 400 (6.5%) from cardiovascular causes. Restricted cubic spline analysis revealed a positive association between EASIX and both all-cause and cardiovascular mortality. Weighted multivariable Cox regression indicated that each 1-unit increase in EASIX corresponding to a 25% and 23% rise in mortality risk, respectively. Based on the optimal cutoff value determined using the maximally selected rank statistics method, participants were stratified into higher (>0.79) and lower (≤0.79) EASIX groups. Higher EASIX was significantly associated with increased all-cause mortality risk (HR 1.46, 95% CI 1.23-1.73, p < 0.0001). Higher EASIX scores were associated with increased cardiovascular mortality, especially in former/current smokers and those with diabetes/prediabetes. Time-dependent receiver operating characteristic analysis assessed the predictive accuracy of EASIX, yielding area under the curve (AUC) for 1-, 3-, 5-, and 10-year survival of 0.71, 0.67, 0.67, and 0.67 for all-cause mortality and 0.79, 0.73, 0.73, and 0.71 for cardiovascular mortality. In conclusion, elevated EASIX is independently associated with increased all-cause and cardiovascular mortality in hypertensive patients, suggesting its potential as a predictive biomarker in clinical practice.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2025) conducted a cohort in Hypertension (n=6,138). Elevated Endothelial Activation and Stress Index (EASIX >0.79) vs. Lower EASIX (≤0.79) was evaluated on All-cause mortality (HR 1.46, 95% CI 1.23-1.73, p=<0.0001). An elevated Endothelial Activation and Stress Index (>0.79) was associated with a 46% increased risk of all-cause mortality in patients with hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: